He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.

Stéphane Bancel has been Moderna's Chief Executive Officer since October 2011 and has served on Moderna’s board of directors since March 2011. Prior to joining Moderna, Mr. Bancel was the Chief Executive Officer of the French diagnostics company bioMérieux SA for five years.

4 days ago · Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly 5.5% stake in the publicly...

We are creating an inclusive and diverse working environment that encourages and rewards curiosity, collaboration and agility. Meet our executive team & Board of Directors who are …

In November 2024, Moderna Inc. announced that Stéphane Bancel, currently serving as Chief Executive Officer, will step down from his role as Chief Commercial Officer while continuing as CEO. Moderna's President, Stephen Hoge, will take over responsibilities for the company's sales, medical, and research affairs.

Feb 7, 2024 · Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna's board of directors since March 2011. In the 13 years since he joined Moderna, Mr. Bancel has led the company from startup to global commercial enterprise.

Oct 27, 2022 · Stéphane Bancel serves as the Chief Executive Officer (CEO) of Moderna Inc. He’s been a part of the company’s board of directors since March 2011. He oversees all company operations and...

Aug 27, 2021 · Stéphane Bancel is Moderna’s CEO and a biochemical engineer. Olivier Leclerc is a senior partner in McKinsey’s Los Angeles office. The authors wish to thank Jennifer Heller, Adam Sabow, Jeff Smith, and Ramesh Srinivasan for their contributions to this article.